PlexusDx emphasizes precision-wellness through genetic screening and licensed 503A compoundingcomplementary approaches to understanding which patient may benefit from specific GLP-1 compounds based on predispositions in peptide pathways
Polygenic disorders Disorders that are caused by the combined effect of multiple variants in different genes
Inhibiting LOX and ACSL4 activity may effectively prevent chondrocyte ferroptosis and decelerate OA development
Ozempic pill is the only oral GLP-1 medicine approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events across both primary prevention (lowering the risk of major cardiovascular events in people who are at higher risk) and secondary prevention (reducing the chance of another cardiovascular event in people who have already had one)
Getting coverage approved requires understanding your plans specific requirements, providing thorough documentation, and knowing how to appeal if initially denied

Endoscopic Surveillance for Barretts Esophagus: Two-Year Results by Lisa Astor "The burden of Barretts surveillance on endoscopic resources can be significant, and it may be appropriate to lengthen the surveillance interval or consider offering at-need endoscopy to well-informed patients." Global Consensus Streamlines MASLD/MASH Care by Amy Pfeiffer "We have developed consensus recommendations for busy clinicians." Peyers patch B cells drive TG2 autoantibodies in celiac disease by Stephanie Vine B-cell-directed therapies have not yet been explored for the treatment of celiac disease, but they might well be pursued in the future given their success for the other autoimmune diseases." AGA releases updated gastroparesis guideline by Amy Pfeiffer The guideline panel "critically assessed the studies available for diagnosing gastroparesis and the treatments used for gastroparesis." CT Findings Differ in Ischemic Colitis Subtypes by Stanley Gajete Abdominal CT imaging showed 100% positivity in more extensive ischemic colitis cases versus just 18% in mild disease, highlighting imaging's diagnostic value for severity assessment
